Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay
(Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the ...
GlobalData on MSN3 天
FDA clears Hologic’s Aptima SARS-CoV-2 assay
Hologic's Panther system, on which the assay runs, processes the samples, delivering initial outcomes in under three hours.
Morningstar4 天
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay
The Aptima SARS-CoV-2 Assay is an in vitro diagnostic test that detects SARS-CoV-2 RNA from nasopharyngeal (NP) or nasal swab samples obtained from people exhibiting signs and symptoms of a ...
来自MSN7 个月
Frequent infections and pathobionts boost children's nasal immunity, study reveals
They collected nasopharyngeal (NP) swab samples from individuals aged ≤ 22 between June 3 and July 2, 2021, a period with relatively few pediatric COVID-19 cases, and in January 2022 ...
Medscape9 年
The Efficacy and Duration of Protection of Pneumococcal Conjugate Vaccines Against ...
Background: Pneumococcal conjugate vaccines (PCVs) reduce disease largely through their impact on nasopharyngeal (NP) carriage acquisition of Streptococcus pneumoniae, a precondition for ...